Jonathan Sessler
Founder at Innovotex, Inc.
Profile
Jonathan Sessler is the founder of Pharmacyclics LLC, which was founded in 1991.
He is also the founder of InnovoTEX, Inc. Currently, he is a Professor of Chemistry at The University of Texas at Austin since 1984.
He previously worked as an Independent Director at Intelligent Bio Solutions, Inc. from 2019 to 2022.
Dr. Sessler earned his doctorate degree from Stanford University in 1982 and his undergraduate degree from the University of California, Berkeley.
Jonathan Sessler active positions
Companies | Position | Start |
---|---|---|
The University of Texas at Austin | Corporate Officer/Principal | 1983-12-31 |
Innovotex, Inc.
Innovotex, Inc. Miscellaneous Commercial ServicesCommercial Services Innovotex, Inc. engages in research and development and manufactures pharmaceuticals to treat cancer. The company is located in the US. | Founder | - |
Former positions of Jonathan Sessler
Companies | Position | End |
---|---|---|
INTELLIGENT BIO SOLUTIONS INC. | Director/Board Member | 2022-02-21 |
PHARMACYCLICS, INC. | Founder | - |
Training of Jonathan Sessler
Stanford University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INTELLIGENT BIO SOLUTIONS INC. | Health Services |
Private companies | 2 |
---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Innovotex, Inc.
Innovotex, Inc. Miscellaneous Commercial ServicesCommercial Services Innovotex, Inc. engages in research and development and manufactures pharmaceuticals to treat cancer. The company is located in the US. | Commercial Services |
- Stock Market
- Insiders
- Jonathan Sessler